Lumos Diagnostics Holdings Ltd (asx:LDX) Share Price

Company Profile

Business description
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services. The Company operates in two geographical regions, the United States and Australia and the majority of revenue is generated from the United States.
Contact
2724 Loker Avenue West
CarlsbadCA92010
USA
T: +1 855 586-6739
https://www.lumosdiagnostics.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2026
Employees

Recommended

AI is reshaping ASX tech moats - but some are more insulated than others.

Tyger Fitzpatrick | 22 March 2026

Patient investors should consider building a position in this wide-moat stock while it’s seriously undervalued.

Dan Romanoff, CPA | 20 March 2026

Sims guides huge earnings upgrade as data center metals demand spikes.

Esther Holloway | 20 March 2026

Index	Last price	Change	% Change
All Ordinaries	8,552.60	77.00	0.91%
CAC 40	7,801.77	136.15	1.78%
DAX 40	22,875.96	495.77	2.22%
Dow JONES (US)	46,464.47	887.00	1.95%
FTSE 100	9,974.45	56.12	0.57%
HKSE	24,382.47	894.85	-3.54%
NASDAQ	22,037.28	389.67	1.80%
Nikkei 225	51,515.49	1,857.04	-3.48%
NZX 50 Index	12,899.72	90.27	-0.69%
S&P 500	6,613.26	106.78	1.64%
S&P/ASX 200	8,365.90	82.40	0.99%
SSE Composite Index	3,813.28	143.77	-3.63%